Community Screening for Nonischemic Cardiomyopathy in Asymptomatic Subjects ≥65 Years With Stage B Heart Failure
Hong Yang1, Ying Wang1, Mark Nolan1
1Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Insights
This study developed an effective heart failure (HF) screening process using clinical risk scores and electrocardiograms (ECG). The new method identifies individuals at high risk for developing HF, enabling targeted prevention strategies.
Area of Science:
- Cardiology
- Preventive Medicine
- Biostatistics
Background:
- Early identification of individuals at risk for heart failure (HF) is crucial for effective screening and prevention strategies.
- Existing risk scores may not fully capture the complexity of HF development in asymptomatic older adults.
- Integrating clinical, functional, and electrocardiographic data can potentially improve risk stratification.
Purpose of the Study:
- To develop and validate an effective screening process for identifying individuals at high risk of developing heart failure (HF).
- To integrate clinical risk scores, functional capacity (6-minute walk test), and electrocardiogram (ECG) findings for improved HF risk prediction.
- To compare the effectiveness of the Atherosclerosis Risk in Communities (ARIC) score against the Framingham HF score.
Main Methods:
- A cohort of asymptomatic subjects aged 65 years and older with at least one HF risk factor was recruited.
- Participants underwent clinical evaluation, HF risk assessment (Framingham HF score, ARIC score), ECG, echocardiography, and a 6-minute walk (6 MW) test.
- A classification and regression tree (CART) analysis was used to integrate ARIC score and 6 MW data for risk stratification, with abnormal ECG further refining intermediate-risk groups.
Main Results:
- The ARIC score demonstrated higher predictive accuracy for incident HF than the Framingham HF score (AUC 0.65 vs 0.53, p=0.01).
- CART analysis identified ARIC score (>9.5%) and 6 MW (<501 m) as key predictors, defining low, intermediate, and high-risk groups.
- The high-risk group identified by the combined strategy showed significantly more echocardiographic signs of cardiac dysfunction and a higher incidence of new HF (20% vs 10%, p=0.003).
Conclusions:
- A combined clinical risk assessment (ARIC score) and electrocardiographic (ECG) strategy effectively identifies a high-risk population for heart failure.
- This screening approach facilitates targeted interventions and prevention efforts in individuals predisposed to HF.
- The integration of functional capacity (6 MW) and ECG findings enhances the precision of HF risk stratification.
Abstract:
A process to identify and target a selected population at risk of heart failure (HF) could facilitate screening and prevention. We sought to develop an effective screening process from clinical characteristics, functional capacity, and electrocardiogram (ECG). Asymptomatic subjects ≥65 years, with ≥1 HF risks were recruited from the community. Subjects with valvular disease, ejection fraction <40%, and atrial fibrillation were excluded. All underwent clinical evaluation including assessment of HF risk using Framingham HF score and Atherosclerosis Risk in Communities (ARIC) score, ECG, echocardiography, and 6-minute walk (6 MW) test. After 14 ± 4 months, new HF was assessed using Framingham criteria. A randomly selected derivation cohort was used to integrate ARIC score and 6 MW in a classification and regression tree (CART) analysis, with the remaining population used for validation. Of the 419 subjects (age 70 ± 5; 48% men), 52 developed HF. ARIC was more effective than the Framingham HF score (area under the curve 0.65 vs 0.53, p = 0.01). CART selected ARIC (>9.5%) and 6 MW (<501 m) as cutoffs to define low-, intermediate-, and high-risk groups. Abnormal ECG further divided the intermediate group into high and low risks. The 134 subjects identified as high risk by a combined clinical and electrocardiographic strategy showed more echocardiographic features of cardiac dysfunction including LV mass, mitral e', mitral E/e', and longitudinal strain (p <0.01). New HF was significantly more frequent than in the remaining patients (20% vs 10%, p = 0.003; hazard ratio 2.08, 95% confidence interval 1.21 to 3.57, p = 0.008). Thus, initial clinical risk and electrocardiographic assessment facilitate effective HF screening by identifying a high-risk group.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
Imaging Studies for Cardiovascular System V: CT
